Table 1 Association between MSH6 expression and clinicopathological characteristics using logistic regression.
From: MSH6 as a prognostic biomarker in bladder cancer and its correlation with immunity
Characteristics | Total (N) | OR (95% CI) | P value |
|---|---|---|---|
Age (> 70 vs. < = 70) | 412 | 1.000 (0.677–1.476) | 1.000 |
Gender (Male vs. Female) | 412 | 0.739 (0.476–1.149) | 0.180 |
BMI (> 25 vs. < = 25) | 362 | 1.141 (0.751–1.733) | 0.537 |
Race (Black or African American vs. Asian &White) | 395 | 1.372 (0.587–3.207) | 0.466 |
Primary therapy outcome (PR&CR vs. PD&SD) | 355 | 0.553 (0.346–0.884) | 0.013 |
Histologic grade (Low grade vs. High grade) | 409 | 0.045 (0.006–0.339) | 0.003 |
Lymphovascular invasion (Yes vs. No) | 281 | 0.709 (0.442–1.136) | 0.153 |
Pathologic stage (Stage III& Stage IV vs. Stage I& Stage II) | 410 | 1.336 (0.883–2.024) | 0.171 |
